Our infection prevention
solutions reduce the risk of
infections, increase patient
safety and reduce the use of
antibiotics.

Bactiguard Holding AB (publ) published the interim report for the first quarter of 2022 on Wednesday, April 27, 2022, at 08.00 and holds the Annual General Meeting via postal vote on April 29, 2022.

In connection with this, an audiocast for shareholders, investors and analysts was held at 11:00 CET on April 27. CEO Anders Göransson and CFO Gabriella Björknert Caracciolo presented the interim report and answered questions.

Presentation

Bactiguard’s BIP Foley catheters decrease the risk of catheter associated urinary tract infection by 69%.

Each year 1 of 10 patients are affected by healthcare associated infections, HAI, globally. The most common HAI is urinary tract infection and a large majority is caused by indwelling urinary catheters.